ArticleBreast cancer research : BCR2026
BHLHE22, targeted by deubiquitinating enzyme OTUD3, exerts an antitumor role in triple-negative breast cancer progression via transcriptionally inhibiting CDT1.
Lei Jiang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.